Visitor Restrictions  |  COVID-19 Vaccine and Boosters  |  COVID-19 Testing

Menu
Close Search Opener

NRG GU009-Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT*)

February 02, 2021
https://www.clinicaltrials.gov/ct2/show/NCT04513717
Cancer - Prostate
Principal Investigator: Eleanor M Walker, MD
CANCER, PROSTATE, PROSTATE CANCER
In Progress